[ad_1]
While the Corona virus continues to die around the world, all eyes are on the official approval of vaccines. The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) continue to investigate the corona virus vaccine developed by Pfizer and BioNTech.
While those studies continued unabated, surprise news arrived today from the partnership of the two vaccine manufacturers. It has been announced that the AstraZeneca vaccine developed in the UK will be combined with the Sputnik V vaccine produced in Russia. The official Sputnik V Twitter account read: “Today a new era of cooperation in the field of vaccines has begun. AstraZeneca accepted our offer ”.
WILL CONTINUE IN GAMALE
Experts think that the formula obtained by combining the two vaccines may be more effective against the virus. The study is expected to start soon, it will be tested whether the two vaccines can be used together. The process in question is claimed to be carried out by the Gamaleya Institute in Russia, which developed the Sputnik V vaccine.
AstraZeneca, which was shown to be a pioneer at the beginning of vaccine studies, was announced to have an efficiency rate of 70 percent and Sputnik V exceeded 90 percent.
It may interest you
It may interest you
[ad_2]
